ALGN MEXC RealStocks
Own real ALGN shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 12:19:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Align Technology Inc. (ALGN) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $164.84, with a market capitalization of $11.52B and a P/E ratio of 23.42. Over the past 52 weeks, its price has ranged from $131.95 to $200.44. This page covers its latest market performance, valuation, price trends and company information.
$11.52B | |
$164.05 | |
$164.84 | |
$164.05 | |
$163.96 | |
134.00 | |
1.01M | |
23.42 | |
$200.44 | |
$131.95 | |
-- | |
2026-09-30 |
Align Technology Inc. (ALGN) is trading at $164.84 in pre-market trading as of 2026-11-19 09:02:00, up 0.54% ($0.88) from the previous close of $163.96
Pre-market trading shows how investors are pricing ALGN before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Align Technology Inc. (ALGN) moved from $174.26 to $164.84, representing a decline of 5.41% ($9.42).
The stock traded between $160.65 and $175.81 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.01 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 48.0%
ALGN is currently trading at $164.84, placing it 48.0% of the way from its 52-week low of $131.95 to its 52-week high of $200.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling a lion's share of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. Invisalign treats over 2 million cases annually, or roughly 10% of all orthodontic cases and has treated over 20 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 20,180 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Align Technology Inc. (ALGN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ALGN, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ALGN shares and USD.
ALGN Shares to USD
1.00 ALGN shares = 164.84 USD
Calculations are estimates based on the latest available price and are for reference only.